Nvidia Could Rake In Billions From New Chip Sales to China. Jensen Huang Is 'Fired Up'

Nvidia has received clearance from both the U.S. and China to resume H200 AI-chip sales to China; initial Chinese approvals could cover several hundred thousand H200s worth an estimated ~$10 billion. CEO Jensen Huang said the supply chain is 'fired up,' the company has received purchase orders and is restarting manufacturing, and management views China as a potential ~$50 billion annual market. Analysts have largely not yet incorporated China H200 revenue into estimates; Nvidia reported FY (ended Jan) adjusted EPS $4.77 on $215.94B revenue, and current market reaction was muted, but this development could add billions to revenue if shipments scale.

Analysis

This clearance is a demand re‑acceleration event more than a one‑off order: the immediate P&L impact will depend on the pace of revenue recognition vs. the pace of manufacturing and customer deployment. If China customers import at scale, expect backend‑loaded revenue over the next 2–4 quarters as datacenter integrations and software stack validations complete; that timing will compress working capital for OEMs and could create a transient mismatch between shipped units and recognized revenue. Margins should expand at the company level only if yield curves and unit mix favor the newest, highest‑ASP SKUs—otherwise revenue growth could be margin‑neutral after channel inventory and promotional displacement of older cards are accounted for.

Second‑order supply‑chain winners are specialist subsystems: liquid cooling suppliers, server integrators, and power delivery component makers who will see multiquarter order visibility and pricing power versus generalist PCB and commodity memory vendors. Conversely, competitors that compete on price rather than architecture (CPU vendors, lower‑tier accelerators) will face downward pressure in tendered bids as hyperscalers prioritize per‑inference efficiency; Chinese domestic accelerator startups face a longer ramp unless they get aggressive subsidized procurement. A nonobvious effect: increased imports accelerate the secondary market for older datacenter GPUs, which will mute new‑unit ASPs for one to two quarters and can be a leading indicator of demand saturation if resale volumes spike.

Tail risks are geopolitical reversals, audit/dispute over the revenue‑sharing or export‑control compliance, and logistics bottlenecks at the board and chassis level; any of these can flip expected revenue from a multi‑quarter stream into a 30–90 day delay. Key catalysts to watch: next quarterly report (revenue recognition language and backlog disclosure), customs/clearance filings and partner purchase orders over the next 4–12 weeks, and TSMC/OSAT capacity statements that determine whether Nvidia can actually scale production without margin erosion. The market likely underweights both the upside of sustained China hyperscaler adoption (structural recurring demand) and the short‑term risk that channel inventory mismatches create noisy quarter‑to‑quarter EPS beats/misses.

Key Decisions for Investors

• Buy NVDA equity (add to core overweight) with a 6–12 month horizon: position size 4–6% of risk budget. Thesis: upside if high‑end ASPs hold and Chinese deployments scale; set a tactical stop at -18% and take‑profit tranches at +30% and +60% given binary policy tail risks.
• Pair trade: long NVDA / short AMD (equal notional) for 3–9 months to capture divergence in datacenter GPU pricing power. Rationale: NVDA retains architecture lock for large language model inference; hedge protects vs sector‑wide multiple expansion. Trim on NVDA +40% or AMD outperformance >20%.
• Options collar: buy NVDA Jan‑2028 LEAP call (OTM) and sell 3–6 month calls to finance ~50–70% of premium. Use a 12–18 month time horizon to capture delayed revenue recognition; this captures convex upside from structural China demand while monetizing near‑term vol that will compress after official shipment confirmation.
• Event/volatility trade: buy short‑dated straddle 2–4 weeks into the next quarterly report only if guidance language is ambiguous; otherwise sell premium 1–2 weeks after a confirmed revenue ramp to collect decompression in IV. Risk: large guidance misses or renewed geopolitical headlines can blow up short premium positions—cap exposure to 1–2% of portfolio.